Crocs
CROX
175 hedge funds and large institutions have $1.14B invested in Crocs in 2014 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 45 increasing their positions, 70 reducing their positions, and 37 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
2% less capital invested
Capital invested by funds: $1.17B → $1.14B (-$26.9M)
3% less funds holding
Funds holding: 181 → 175 (-6)
14% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 37
36% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 70
51% less call options, than puts
Call options by funds: $19.1M | Put options by funds: $38.9M
Top Buyers
Top Sellers
| 1 |
RA
Royce & Associates
New York
|
-$27.6M |
| 2 |
SAM
Scopus Asset Management
New York
|
-$18.7M |
| 3 |
Millennium Management
New York
|
-$9.49M |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$9.36M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$8.58M |
CROX Hedge Fund Activity: Q1 2014 in Review
175 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Crocs (CROX) for Q1 2014, worth a combined $1.14B — down 2.3% from $1.17B a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of CROX and 32 opened new positions — a net loss of 5 holders — while 70 trimmed existing stakes and 45 added.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $41.7M. The largest seller was Royce & Associates, cutting an estimated $27.6M.
- 175 institutional investors held Crocs (CROX) as of Q1 2014, down from 181 in Q4 2013.
- Funds reported $1.14B of Crocs stock for Q1 2014, down 2.3% quarter-over-quarter.
- 32 funds opened new Crocs positions in Q1 2014 and 37 closed out, a net change of -5 holders.
- The largest Crocs buyer in Q1 2014 was Fidelity Investments, an estimated $41.7M added.
- The largest Crocs seller in Q1 2014 was Royce & Associates, an estimated $27.6M sold.
Based on aggregated 13F filings for Q1 2014.